Pluronic F127/poly(lactic acid) nanoparticles as drug carriers

李资玲,黄优生,熊向源,龚妍春,李玉萍
DOI: https://doi.org/10.3969/j.issn.2095-4344.2012.51.006
2012-01-01
Abstract:BACKGROUND:Few reports about the stability of nanoparticles in the water and PBS have been published in China. OBJECTIVE:To investigate the stability of pluronic/poly(lactic acid) nanoparcticles in the water and PBS and feasibility of pluronic F127/poly(lactic acid) block polymer as drug carriers METHODS:Pluronic poly(lactic acid) nanoparcticles were prepared by a dialysis method. In vitro high performance liquid chromatography, and the cytotoxicity of pluronic F127/poly(lactic acid) block polymer was investigated by MTT. RESULTS AND CONCLUSION:Pluronic/poly(lactic acid) nanoparticles had better stability in the water than in the PBS. In addition, pluronic/poly(lactic acid) nanoparticles were influenced greatly by the temperature, which had a good stability in low temperature. At 37 ℃, pluronic/poly(lactic acid) nanoparticles had a greater change in the particle size. The release curve of paclitaxel-loaded pluronic F127/poly(lactic acid) nanoparticles showed a rapid release within 20 hours, and then presented with a slow release. Approximately 20%paclitaxel was released from the nanoparticles. MTT test results revealed that pluronic F127/poly(lactic acid) block polymer had a good biocompatibility. These findings indicate that pluronic/poly(lactic acid) nanoparticles can be used as drug carriers.
What problem does this paper attempt to address?